{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:57Z","timestamp":1786119177664,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/fjc.0b013e31817d4507","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T15:34:16Z","timestamp":1236267256000},"page":"28-34","source":"Crossref","is-referenced-by-count":18,"title":["Treatment of Coronary Spastic Angina With a Statin in Addition to a Calcium Channel Blocker: A Pilot Study"],"prefix":"10.1097","volume":"52","author":[{"given":"Shigemasa","family":"Tani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Anazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Kawamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Fuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamichi","family":"Kumabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210208","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0735-1097(98)00447-1","article-title":"Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina.","volume":"32","author":"Motoyama","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R2-5-20210208","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0021-9150(00)00494-9","article-title":"Increase in plasma levels of oxidized low-density lipoproteins in patients with coronary spastic angina.","volume":"154","author":"Kugiyama","year":"2001","journal-title":"Atherosclerosis"},{"key":"R3-5-20210208","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0021-9150(92)90204-T","article-title":"Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies.","volume":"93","author":"Hoffman","year":"1992","journal-title":"Atherosclerosis"},{"key":"R4-5-20210208","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199502233320801","article-title":"Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease.","volume":"332","author":"Treasure","year":"1995","journal-title":"N Engl J Med"},{"key":"R5-5-20210208","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1253\/circj.67.1029","article-title":"Lesion severity and hypercholesterolemia determine long-term prognosis of vasospastic angina treated with calcium channel antagonists.","volume":"67","author":"Yamagishi","year":"2003","journal-title":"Circ J"},{"key":"R6-5-20210208","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00004872-200103000-00013","article-title":"A calcium channel blocker, benidipine, inhibits intimal thickening in the carotid artery of mice by increasing nitric oxide production.","volume":"19","author":"Yamashita","year":"2001","journal-title":"J Hypertens"},{"key":"R7-5-20210208","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1248\/bpb.23.766","article-title":"Antioxidant effects of calcium antagonists in rat brain homogenates.","volume":"23","author":"Yao","year":"2000","journal-title":"Biol Pharm Bull"},{"key":"R8-5-20210208","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.ki.5000431","article-title":"Decrease in tetrahydrobiopterin as a possible cause of nephropathy in type diabetic rats.","volume":"70","author":"Okumura","year":"2006","journal-title":"Kidney Int"},{"key":"R9-5-20210208","first-page":"505","article-title":"Antioxidative effects of benidipine hydrochloride in patients with hypertension independent of antihypertensive effects. Relationship between blood pressure and oxidative stress.","volume":"54","author":"Suzuki","year":"2004","journal-title":"Arzneimittelforschung"},{"key":"R10-5-20210208","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1291\/hypres.28.107","article-title":"Benidipine, a long-acting calcium channel blocker, inhibits oxidative stress in polymorphonuclear cells in patients with essential hypertension.","volume":"28","author":"Yasunari","year":"2005","journal-title":"Hypertens Res"},{"key":"R11-5-20210208","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0895-7061(98)00260-X","article-title":"Benidipine stimulates nitric oxide synthase and improves coronary circulation in hypertensive rats.","volume":"12","author":"Kobayashi","year":"1999","journal-title":"Am J Hypertens"},{"key":"R12-5-20210208","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1248\/bpb.23.766","article-title":"Antioxidant effects of calcium antagonists in rat brain homonenates.","volume":"23","author":"Yao","year":"2000","journal-title":"Bio Pharm Bull"},{"key":"R13-5-20210208","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/FJC.0b013e3181624b05","article-title":"Prognostic effects of benidipine in patients with vasospastic angina: comparison with diltiazem and amlodipine.","volume":"51","author":"Fukumoto","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"R14-5-20210208","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0735-1097(01)01682-5","article-title":"AHA\/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update.","volume":"38","author":"Smith","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R15-5-20210208","first-page":"107","article-title":"Singe LDL apheresis improves serum remnant-like particle-cholesterol, C-reactive protein, and malondialdehyde-modified-low-density lipoprotein concentrations in Japanese hypercholesterolemic subjects, Clin Chim Acta.","volume":"321","author":"Kobayashi","year":"2002","journal-title":""},{"key":"R16-5-20210208","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.ATV.14.1.32","article-title":"Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.","volume":"14","author":"Yla-Herttuala","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"R17-5-20210208","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1253\/circj.66.1037","article-title":"High-density lipoprotein cholesterol and the role of statins.","volume":"66","author":"Chong","year":"2002","journal-title":"Circ J"},{"key":"R18-5-20210208","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.metabol.2004.01.004","article-title":"The relationships of vigorous exercise, alcohol, and adiposity to low and high high-density lipoprotein-cholesterol levels.","volume":"53","author":"Williams","year":"2004","journal-title":"Metabolism"},{"key":"R19-5-20210208","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0002-9149(97)00965-X","article-title":"Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).","volume":"81","author":"Jones","year":"1998","journal-title":"Am J Cardiol"},{"key":"R20-5-20210208","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0002-9149(02)02575-4","article-title":"Direct association between high-density lipoprotein cholesterol and endothelial function in hyperlipemia.","volume":"90","author":"Lupattelli","year":"2002","journal-title":"Am J Cardiol"},{"key":"R21-5-20210208","first-page":"373","article-title":"Increased HDL-cholesterol level improves the prognosis in patients with coronary vasospasm.","volume":"24","author":"Miwa","year":"1994","journal-title":"J Cardiol"},{"key":"R22-5-20210208","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1096\/fj.01-0273rev","article-title":"Oxidized LDL and HDL: antagonists in atherothrombosis.","volume":"15","author":"Mertens","year":"2001","journal-title":"FASEB J"},{"key":"R23-5-20210208","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ijcard.2006.11.218","article-title":"A case of vasospastic angina showing resolution of coronary vasospasm in acetylcholine provocation test corresponding to regression of coronary atherosclerosis.","volume":"125","author":"Tani","year":"2008","journal-title":"Int J Cardiol"},{"key":"R24-5-20210208","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJM198610233151702","article-title":"Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries.","volume":"315","author":"Ludmer","year":"1986","journal-title":"N Engl J Med"},{"key":"R25-5-20210208","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.amjcard.2005.05.069","article-title":"Effect of pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by three-dimensional intravascular ultrasound.","volume":"96","author":"Tani","year":"2005","journal-title":"Am J Cardiol"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005344-200807000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:45:20Z","timestamp":1786038320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005344-200807000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0b013e31817d4507","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}